Reckitt Benckiser Group PLC (RBGLY) Downgraded by Zacks Investment Research to Hold
According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “
RBGLY has been the subject of several other reports. Citigroup Inc. began coverage on shares of Reckitt Benckiser Group PLC in a research note on Thursday, September 1st. They issued a buy rating for the company. JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group PLC from an overweight rating to a neutral rating in a research note on Thursday, June 30th. Credit Suisse Group AG decreased their price target on shares of Reckitt Benckiser Group PLC from $6,500.00 to $6,100.00 and set an outperform rating for the company in a research note on Thursday, August 25th. Macquarie began coverage on shares of Reckitt Benckiser Group PLC in a research note on Thursday, June 30th. They issued an outperform rating for the company. Finally, BNP Paribas lowered shares of Reckitt Benckiser Group PLC from an outperform rating to a neutral rating in a research note on Wednesday, September 7th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $4,155.75.
Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) traded down 0.9688% during mid-day trading on Thursday, reaching $18.4099. 19,207 shares of the company’s stock traded hands. Reckitt Benckiser Group PLC has a 12-month low of $17.03 and a 12-month high of $20.70. The firm’s 50 day moving average price is $19.41 and its 200-day moving average price is $19.71. The stock has a market cap of $64.90 billion, a price-to-earnings ratio of 32.5263 and a beta of 0.90.
About Reckitt Benckiser Group PLC
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA, DvM and Food. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Stock Ratings for Reckitt Benckiser Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group PLC and related stocks with our FREE daily email newsletter.